CMS Issues Final Rule on 2019 Part D Plans

On Monday, April 2, 2018, the Centers for Medicare & Medicaid Services released its final rule and call letter for 2019 Medicare Part D and Medicare Advantage plans. While KPSC, IPC, and our partners in Washington review this 1,000 page rule from CMS, we wanted to provide you with NCPA’s update on some of the…

Read More

Walmart-Humana Merger

Another potential healthcare merger was announced last week with Walmart and health insurer, Humana, entering talks to join forces. Walmart is reportedly unlikely to take acquisition of Humana, but the deal could result in a “financial and operating partnership around prescription drug sales or insurance coverage,” according to the New York Times. For Walmart, the…

Read More

Pharmacists’ Role in Diabetes Care

Today is the American Diabetes Association Alert Day. On this day, the ADA strives to raise awareness for type 2 diabetes. In the United States, 11.3% of people 20 and older have type 2 diabetes. For every four Americans who have type 2 diabetes, one is undiagnosed. Pharmacists, especially independent pharmacists, who are the primary…

Read More

NCPA Fighting Back on Mergers

The last few weeks have seen some major shakeups in the pharmacy industry. On Tuesday, Feb. 27, the House Judiciary Subcommittee on Regulatory Reform, Commercial and Antitrust Law in Washington, D.C. met to discuss the proposed $69 billion CVS Health-Aetna merger. NCPA provided a statement to the subcommittee on behalf of independent pharmacies across the…

Read More

KPSC Holds EOG Presentation with KU Pharmacy Students

Last night, KPSC held its annual Entrepreneurial Opportunities Group (EOG) presentation with student-members of the NCPA chapter group at the KU School of Pharmacy. For the sixth year in a row, a representative from the RxOwnership branch of McKesson came and presented to the students. This year it was Regional Manager, Nick Secrest, who graciously…

Read More

Latest on the Opioid Epidemic

According to the National Institutes of Health (NIH), an estimated 2 million Americans are currently addicted to opioids and for Americans under the age of 50, drug overdose is the #1 cause of death. As a result, the NIH has begun partnering with pharmaceutical companies to conduct scientific research on how to develop non-addictive painkillers…

Read More

Healthy Community, Healthy Economy: The Pharmacy Effect on the Kansas Economy

Did you know that in 2020, the amount of total health care expenditures in the state of Kansas is projected to be $4.2 billion? According to Dr. John Leatherman of the Department of Agricultural Economics at Kansas State University, that projection will soon become a reality. The study conducted by Dr. Leatherman is titled “The…

Read More

Amazon Shaking up the Healthcare Industry

On Tuesday, Jan. 30, 2018 it was announced that Amazon, JPMorgan Chase, and Berkshire Hathaway are teaming up to enter the healthcare industry. The move was made to improve health care for their employees by utilizing new technology that provides a more affordable, high-quality, and transparent healthcare service. The effects of the partnership could transform…

Read More

NCPA Continuing Fight to Move DIRs to Point of Sale

National Community Pharmacists Association (NCPA) is continuing to urge CMS to adopt the proposed changes to DIR fees. NCPA led an effort along with pharmacy stakeholders and Senators in Washington to generate support for a letter expressing bipartisan support to CMS for its approach to pharmacy DIR fees. The letter was organized by U.S. Senators…

Read More